| Title | Recent Patents on Inflammation and Allergy Drug Discovery |
| Abbreviation | Recent Pat. Inflamm. Allergy Drug Discov. |
| Publication Type | Journal |
| Subject Area, Categories, Scope | Drug Discovery (Q1); Medicine (miscellaneous) (Q1); Immunology and Allergy (Q2) |
| h-index | 0 |
| Overall Rank/Ranking | 4975 |
| SCImago Journal Rank (SJR) | 0.879 |
| Impact Score | 0.00 |
| Publisher | Bentham Science Publishers B.V. |
| Country | United Arab Emirates |
| ISSN | 1872213X, 22122710 |
| Best Quartile | Q1 |
| Coverage History | 2007-2020 |
Recent Patents on Inflammation and Allergy Drug Discovery is a journal covering the technologies/fields/categories related to Drug Discovery (Q1); Medicine (miscellaneous) (Q1); Immunology and Allergy (Q2). It is published by Bentham Science Publishers B.V.. The overall rank of Recent Patents on Inflammation and Allergy Drug Discovery is 4975. According to SCImago Journal Rank (SJR), this journal is ranked 0.879. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 0. The best quartile for this journal is Q1.
The ISSN of Recent Patents on Inflammation and Allergy Drug Discovery journal is 1872213X, 22122710. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Recent Patents on Inflammation and Allergy Drug Discovery is cited by a total of 0 articles during the last 3 years (Preceding 2021).
The impact score (IS) 2021 of Recent Patents on Inflammation and Allergy Drug Discovery is 0.00, which is computed in 2022 as per its definition. The impact score (IS), also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.
IS 2021 of Recent Patents on Inflammation and Allergy Drug Discovery is 0.00. If the same upward trend persists, impact score may rise in 2022 as well.
| Year | Impact Score (IS) |
|---|---|
| 2023/2024 | Coming Soon |
| 2021 | 0.00 |
| 2020 | 0.00 |
| 2019 | 0.00 |
| 2018 | 0.00 |
| 2017 | 0.00 |
| 2016 | 0.00 |
| 2015 | 0.00 |
| 2014 | 0.00 |
Recent Patents on Inflammation and Allergy Drug Discovery has an h-index of 0. It means 0 articles of this journal have more than 0 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.
The ISSN of Recent Patents on Inflammation and Allergy Drug Discovery is 1872213X, 22122710. ISSN stands for International Standard Serial Number.
An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.
The overall rank of Recent Patents on Inflammation and Allergy Drug Discovery is 4975. According to SCImago Journal Rank (SJR), this journal is ranked 0.879. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.
| Year | SJR |
|---|---|
| 2023/2024 | Coming Soon |
| 2021 | 0.879 |
| 2020 | 0.576 |
| 2019 | 0.436 |
| 2018 | 0.405 |
| 2017 | 0.314 |
| 2016 | 0.353 |
| 2015 | 0.421 |
| 2014 | 0.431 |
| Year | Ranking |
|---|---|
| 2023/2024 | Coming Soon |
| 2021 | 4975 |
| 2020 | 8782 |
| 2019 | 11043 |
| 2018 | 11225 |
| 2017 | 12945 |
| 2016 | 12086 |
| 2015 | 10525 |
| 2014 | 10082 |
Recent Patents on Inflammation and Allergy Drug Discovery is published by Bentham Science Publishers B.V.. It's publishing house is located in United Arab Emirates. Coverage history of this journal is as following: 2007-2020. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.
Visit the official website of the journal/conference to check the further details about the call for papers.
The IS0 4 standard abbreviation of Recent Patents on Inflammation and Allergy Drug Discovery is Recent Pat. Inflamm. Allergy Drug Discov.. This abbreviation ('Recent Pat. Inflamm. Allergy Drug Discov.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.
ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.
If your research field is/are related to Drug Discovery (Q1); Medicine (miscellaneous) (Q1); Immunology and Allergy (Q2), then please visit the official website of this journal.
The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.
It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.
The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.
The latest impact index of the Recent Patents on Inflammation and Allergy Drug Discovery is 0.00. It's evaluated in the year 2021. The highest and the lowest impact index or impact score of this journal are 0.00 (2021) and 0.00 (2021), respectively, in the last 8 years. Moreover, its average IS is 0 in the previous 8 years.
The Recent Patents on Inflammation and Allergy Drug Discovery has an SJR (SCImago Journal Rank) of 0.879, according to the latest data. It is computed in the year 2022. In the past 8 years, this journal has recorded a range of SJR, with the highest being 0.879 in 2021 and the lowest being 0.314 in 2017. Furthermore, the average SJR of the Recent Patents on Inflammation and Allergy Drug Discovery over the previous 8-year period stands at 0.
The latest h-index of the Recent Patents on Inflammation and Allergy Drug Discovery is 0.
The Recent Patents on Inflammation and Allergy Drug Discovery is published by the Bentham Science Publishers B.V., with its country of publication being the United Arab Emirates.
The Recent Patents on Inflammation and Allergy Drug Discovery is currently ranked 4975 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 8 years, this journal has experienced varying rankings, reaching its highest position of 4975 in 2021 and its lowest position of 12945 in 2017.
The standard ISO4 abbreviation for the Recent Patents on Inflammation and Allergy Drug Discovery is Recent Pat. Inflamm. Allergy Drug Discov..
Recent Patents on Inflammation and Allergy Drug Discovery is classified as a journal that the Bentham Science Publishers B.V. publishes.
The Recent Patents on Inflammation and Allergy Drug Discovery encompasses the following areas:
For a more comprehensive understanding of its scope, check the official website of this journal.
The Recent Patents on Inflammation and Allergy Drug Discovery is assigned the following International Standard Serial Numbers (ISSN): 1872213X, 22122710.
The best quartile for the Recent Patents on Inflammation and Allergy Drug Discovery is Q1 (2021).
The Recent Patents on Inflammation and Allergy Drug Discovery coverage history can be summarized as follows: 2007-2020.
| Journal/Conference/Workshop/Book Title | Type | Ranking | Publisher | h-index | Impact Score |
|---|---|---|---|---|---|
| SPE Production and Operations Symposium, Proceedings | conference and proceedings | 15907 | 21 | 0.00 | |
| Revue Francophone des Laboratoires (discontinued) | journal | 23244 | Elsevier Masson s.r.l. | 8 | 0.00 |
| Journal of Applied Business Research | journal | 23890 | 29 | 0.28 | |
| Marine Biology Research | journal | 13573 | Taylor and Francis Ltd. | 42 | 1.06 |
| Journal of Sociolinguistics | journal | 5409 | Wiley-Blackwell Publishing Ltd | 61 | 1.96 |
| Educational Measurement: Issues and Practice | journal | 4494 | Wiley-Blackwell Publishing Ltd | 59 | 1.53 |
| European Surgery - Acta Chirurgica Austriaca | journal | 16873 | Springer Medizin | 23 | 0.58 |
| Korean Journal of Applied Microbiology and Biotechnology | journal | 22033 | Korean Society for Applied Microbiology | 0 | 0.00 |
| Oral Radiology | journal | 9461 | Springer Japan | 20 | 2.06 |
| Canadian Journal of Mathematics | journal | 3905 | Canadian Mathematical Society | 43 | 0.79 |
| Year | Impact Score (IS) |
|---|---|
| 2022/2023 | Coming Soon |
| 2021 | 0.00 |
| 2020 | 0.00 |
| 2019 | 0.00 |
| 2018 | 0.00 |
| 2017 | 0.00 |
| 2016 | 0.00 |
| 2015 | 0.00 |
| 2014 | 0.00 |
0.00
0
4975
0.879
